Gastroenteropancreatic Neuroendocrine Tumor Clinical Trials in Dallas, Texas
2 recruitingDallas, Texas
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals240 enrolled65 locationsNCT06784752
Recruiting
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Neuroendocrine TumorsGastroenteropancreatic Neuroendocrine Tumor
Methodist Health System50 enrolled2 locationsNCT04090034